Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/16639739

Cancer 2006 Jun 1 106 11 2445-51

Download in:

View as

General Info

PMID
16639739